BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35385777)

  • 41. Xa inhibitor edoxaban ameliorates hepatic ischemia-reperfusion injury via PAR-2-ERK 1/2 pathway.
    Maeda K; Kuriyama N; Noguchi D; Ito T; Gyoten K; Hayasaki A; Fujii T; Iizawa Y; Murata Y; Tanemura A; Kishiwada M; Mizuno S
    PLoS One; 2024; 19(5):e0292628. PubMed ID: 38748746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways.
    Chilvery S; Bansod S; Saifi MA; Godugu C
    Int Immunopharmacol; 2020 Nov; 88():106909. PubMed ID: 32882664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of the TGF-β/Smad signaling pathway and inhibition of hepatic stellate cell proliferation play a role in the hepatoprotective effects of curcumin against alcohol-induced hepatic fibrosis.
    Chen N; Geng Q; Zheng J; He S; Huo X; Sun X
    Int J Mol Med; 2014 Oct; 34(4):1110-6. PubMed ID: 25069637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of ghrelin on chronic liver injury and fibrogenesis in male rats: possible role of nitric oxide.
    Kabil NN; Seddiek HA; Yassin NA; Gamal-Eldin MM
    Peptides; 2014 Feb; 52():90-7. PubMed ID: 24333973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats.
    Eissa LA; Kenawy HI; El-Karef A; Elsherbiny NM; El-Mihi KA
    Chem Biol Interact; 2018 Oct; 294():91-100. PubMed ID: 30138605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phillygenin Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis: Suppression of Inflammation and Wnt/β-Catenin Signaling Pathway.
    Wang C; Liu Y; Gong L; Xue X; Fu K; Ma C; Li Y
    Inflammation; 2023 Aug; 46(4):1543-1560. PubMed ID: 37219693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ac2-26 attenuates hepatic ischemia-reperfusion injury in mice
    Li W; Jiang H; Bai C; Yu S; Pan Y; Wang C; Li H; Li M; Sheng Y; Chu F; Wang J; Chen Y; Li J; Jiang J
    PeerJ; 2022; 10():e14086. PubMed ID: 36193422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
    Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H
    J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the Alcohol-Induced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells.
    Araújo Júnior RF; Garcia VB; Leitão RF; Brito GA; Miguel Ede C; Guedes PM; de Araújo AA
    PLoS One; 2016; 11(2):e0148868. PubMed ID: 26891124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective effect of pinocembrin from Penthorum chinense Pursh on hepatic ischemia reperfusion injury via regulating HMGB1/TLR4 signal pathway.
    Ma T; Zhang H; Li T; Bai J; Wu Z; Cai T; Chen Y; Xia X; Du Y; Fu W
    Phytother Res; 2023 Jan; 37(1):181-194. PubMed ID: 36097366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New progress in roles of nitric oxide during hepatic ischemia reperfusion injury.
    Zhang YQ; Ding N; Zeng YF; Xiang YY; Yang MW; Hong FF; Yang SL
    World J Gastroenterol; 2017 Apr; 23(14):2505-2510. PubMed ID: 28465634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factor‑β/Smad pathway in rats.
    Huang W; Li L; Tian X; Yan J; Yang X; Wang X; Liao G; Qiu G
    Mol Med Rep; 2015 Feb; 11(2):805-14. PubMed ID: 25373883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endogenous production of n-3 polyunsaturated fatty acids protects mice from carbon tetrachloride-induced liver fibrosis by regulating mTOR and Bcl-2/Bax signalling pathways.
    Shan C; Wang R; Wang S; Zhang Z; Xing C; Feng W; Zhao Z; Zhou S; Zhao AZ; Mu Y; Li F
    Exp Physiol; 2021 Apr; 106(4):983-993. PubMed ID: 33605486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Locostatin Alleviates Liver Fibrosis Induced by Carbon Tetrachloride in Mice.
    Ma J; Qiu Y; Wang M; Zhang M; Zhao X; Jiang H
    Dig Dis Sci; 2019 Sep; 64(9):2570-2580. PubMed ID: 30874989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acidic Microenvironment Aggravates the Severity of Hepatic Ischemia/Reperfusion Injury by Modulating M1-Polarization Through Regulating PPAR-γ Signal.
    Ding W; Duan Y; Qu Z; Feng J; Zhang R; Li X; Sun D; Zhang X; Lu Y
    Front Immunol; 2021; 12():697362. PubMed ID: 34234785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The anti-fibrotic effect of bone morphogenic protein-7(BMP-7) on liver fibrosis.
    Zhong L; Wang X; Wang S; Yang L; Gao H; Yang C
    Int J Med Sci; 2013; 10(4):441-50. PubMed ID: 23471555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Baicalein pre-treatment alleviates hepatic ischemia/reperfusion injury in mice by regulating the Nrf2/ARE pathway.
    Zhou Y; Tan Z; Huang H; Zeng Y; Chen S; Wei J; Huang G; Qian C; Yuan G; He S
    Exp Ther Med; 2021 Dec; 22(6):1380. PubMed ID: 34650628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
    Wang R; Zhang H; Wang Y; Song F; Yuan Y
    Int Immunopharmacol; 2017 Jun; 47():126-133. PubMed ID: 28391159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zygophyllum album leaves extract prevented hepatic fibrosis in rats, by reducing liver injury and suppressing oxidative stress, inflammation, apoptosis and the TGF-β1/Smads signaling pathways. Exploring of bioactive compounds using HPLC-DAD-ESI-QTOF-MS/MS.
    Feriani A; Tir M; Gómez-Caravaca AM; Del Mar Contreras M; Taamalli A; Segura-Carretero A; Ghazouani L; Mufti A; Tlili N; El Feki A; Harrath AH; Allagui MS
    Inflammopharmacology; 2020 Dec; 28(6):1735-1750. PubMed ID: 32206981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.